pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
pharmadog news

Browse

3,246 stories matching this filter · ← front page

★ save view↓export CSV
rangeto
sort
recentoldestsourcealpha
source
STAT1212Endpoints919BioPharma Dive354BioSpace335Fierce Biotech315onclive165raps111globenewswire health73
therapy area
allOncology8157Rare Disease1937Cardiology1879Immunology1557Hematology1354Pulmonology1264Vaccines
  • Trump administration cautions against federal funding for fentanyl test strips and other harm-reduction tools
    The federal agency that oversees addiction and mental health policy sent an open letter to its grant recipients warning them not to spend federal money on harm‑reduction supplies such as sterile sy…
    STAT · 4mo agoRegulatoryNegative↗ source
  • Veradermics reports positive Phase 2/3 results for oral Rogaine in men with pattern hair loss
    Veradermics, a biotech that recently went public, announced that its oral formulation of Rogaine met the primary endpoints in a late-stage Phase 2/3 trial. The study enrolled men with mild-to-mode…
    Endpoints · 4mo agoPositive readoutPositive↗ source
← prev
page 128 of 130
next →
fda recalls71
fda medwatch62
fda press38
1262
Psychiatry & CNS889
Ophthalmology521
Pain501
Endocrinology & Metabolism495
Infectious Disease457
  • Veradermics reports positive late-stage results for oral hair-loss pill VDPHL01
    Veradermics announced that its experimental oral medication VDPHL01 met its primary goals in a Phase 3 trial for male pattern hair loss. Over six months, participants taking the drug once or twice…
    STAT · 4mo agoPositive readoutPositive↗ source
  • Revolution Medicines threatens lawsuit against Erasca over RAS drug patent and efficacy claims
    Earlier this month a newly announced cancer therapy generated strong interest from patients and investors. The drug, which targets the RAS pathway, was highlighted for its potential impact on oncol…
    Endpoints · 4mo agoRegulatoryNegative↗ source
  • Insider explains the true purpose behind prior authorizations in U.S. health insurance
    The STAT+ newsletter article by Bob Herman reports on an interview with Archelle Georgiou, who previously worked at the nation’s largest health insurer and was involved in efforts to curb prior aut…
    STAT · 4mo agoNeutral↗ source
  • STAT+: Astellas retries XLMTM gene therapy after deaths
    Veradermics' hair loss pill late-stage trial success, FDA fast-tracks reviews for psychedelics, and more biotech news
    STAT · 4mo agoRegulatoryNeutral↗ source
  • GLP-1 drugs and eating disorder risk examined as Covid impact wanes in 2026
    The Morning Rounds newsletter explores the potential link between GLP-1 medications and the development of eating disorders, emphasizing that the risk remains uncertain and warrants further study.…
    STAT · 4mo agoNeutral↗ source
  • CDC-funded hepatitis B vaccine trial in Guinea-Bissau paused amid ethical concerns
    The U.S. Centers for Disease Control and Prevention awarded a $1.6 million grant to a Danish research group to compare hepatitis B vaccination at birth versus at six weeks in infants from Guinea‑Bi…
    STAT · 4mo agoRegulatoryNegative↗ source
  • Utah doctors urge state to suspend Doctronic AI prescription-refill program
    Utah medical licensing board members have asked the state to halt a temporary program that lets startup Doctronic use artificial intelligence to refill prescriptions. The board says the AI-driven…
    Endpoints · 4mo agoRegulatoryNegative↗ source
  • NIH-funded studies often omit sex-specific results, study finds
    A new analysis of NIH-funded papers reveals that less than half report outcomes separately for men and women. Researchers examined 574 articles published between 2017 and 2024; while 61% included…
    STAT · 4mo agoRegulatoryNegative↗ source
  • Experts say Covid risk has faded, but boosters still advised for vulnerable groups
    Health journalist Helen Branswell reflects on how Covid-19, once the dominant global threat, has receded in public consciousness. Six years after the 2020 lockdowns, mask-wearing and social distanc…
    STAT · 4mo agoNeutral↗ source
  • Mental health clinicians face contracts that charge patients for staying with them
    Sarah Cady, a psychiatric nurse practitioner near New York City, discovered a clause in an employment contract that would require her to pay $7,500 for each patient who chose to continue treatment…
    STAT · 4mo agoNegative↗ source
  • Democrats criticize Health Secretary Kennedy for not releasing vaccine contract
    Senators asked HHS Secretary Robert F. Kennedy Jr. to release a contract with a longtime vaccine critic by a Friday deadline. Kennedy initially said he would be happy to share it, but the deadline…
    STAT · 4mo agoRegulatoryNegative↗ source
  • UK biotech funding shows early recovery after mid-2025 lull, BIA reports
    The BioIndustry Association released data indicating that equity financing for UK biotech companies is beginning to rise again in early 2026. The trend follows a slowdown that began in mid-2025, w…
    Endpoints · 4mo agoPositive↗ source
  • Integrative medicine doctor Kristine Blanche, wife of acting U.S. attorney general, joins NIH's complementary health advisory council
    Kristine Blanche, an integrative medicine physician and spouse of acting U.S. attorney general Todd Blanche, has been appointed to an NIH advisory council. She will serve on the advisory council f…
    STAT · 4mo agoNeutral↗ source
  • CDC flu research pioneer Nancy Cox dies at 77
    Nancy Cox, a longtime CDC veteran, passed away at age 77 after battling glioblastoma, a form of brain cancer. Cox led the agency's influenza division for 22 years, expanding the team from a modest…
    STAT · 4mo agoNeutral↗ source
  • New Podcast 'Drug Story' Explores the Cultural Impact of Blockbuster Medications
    The First Opinion team has launched a new podcast called “Drug Story,” hosted by journalist and entrepreneur Thomas Goetz. The series aims to uncover the hidden narratives behind widely used medici…
    STAT · 4mo agoPositive↗ source
  • Endpoints Weekly celebrates Neal Awards while previewing Sanofi, Lilly and RevMed updates
    Endpoints Weekly released its latest edition on April 25, 2026, noting a celebratory tone after the publication earned three Neal Awards for B2B journalism excellence. The issue highlights several…
    Endpoints · 4mo agoPositive↗ source
  • Eli Lilly to acquire cancer cell therapy startup Kelonia Therapeutics for $3.2 billion
    Eli Lilly announced it will buy privately held Kelonia Therapeutics, a biotech focused on cell therapies for cancer and autoimmune diseases, in a deal valued at $3.2 billion. Kelonia has operated…
    STAT · 4mo agoDealPositive↗ source
  • European regulators recommend Sanofi's MS drug tolebrutinib for approval after US rejection
    European Medicines Agency officials issued a positive recommendation for tolebrutinib, an experimental multiple sclerosis therapy from Sanofi, after the U.S. FDA rejected the drug earlier this year…
    BioPharma Dive · 4mo agoRegulatoryPositive↗ source
  • Sanofi’s tolebrutinib receives EU CHMP endorsement for specific multiple sclerosis patients despite US FDA setback
    Sanofi's BTK inhibitor tolebrutinib is moving toward approval in the European Union for a subset of multiple sclerosis patients. The Committee for Medicinal Products for Human Use (CHMP) of the Eu…
    Endpoints · 4mo agoRegulatoryPositive↗ source
  • FDA to fast-track review of three psychedelic therapies for depression and PTSD
    The FDA announced it will accelerate the review of psychedelic drugs from three companies as part of a broader initiative to increase access to mental-health treatments. Compass Pathways will rece…
    STAT · 4mo agoRegulatoryPositive↗ source
  • Utah medical board urges halt to AI-driven prescription renewal pilot
    Utah launched a pilot program that partners with AI startup Doctronic to let a chatbot conduct clinical evaluations and automatically renew prescriptions for roughly 200 medications, without direct…
    STAT · 4mo agoRegulatoryNegative↗ source
  • Avalyn Pharma targets $182M IPO as WHO prequalifies Novartis malaria drug
    Avalyn Pharma announced plans for an initial public offering that could raise about $182 million in net proceeds. The company is developing inhaled formulations of drugs already approved for pulmon…
    Endpoints · 4mo agoDealNeutral↗ source
  • Novartis withdraws EU filing for Pluvicto label expansion into early-stage prostate cancer
    Novartis announced it has pulled its application to the European Medicines Agency to extend the label of its radioligand therapy Pluvicto for use in earlier stages of prostate cancer. The move com…
    Endpoints · 4mo agoRegulatoryNegative↗ source